Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 41.1744.02---

What is the latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of CONCORD BIOTECH is 41.17 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202541.17
Mar202444.02
Mar2023-
Mar2022-
Mar2021-

How is Price to Cash Earnings (PCE) of CONCORD BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 41.17
-6.47
Mar2024 44.02
0
Mar2023 0
0
Mar2022 0
0
Mar2021 0 -

Other Financial Ratios of CONCORD BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹13,936.4 Cr -2.7% -11.2% -34.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,705.0 Cr -0.7% 2% -1.7% Stock Analytics
DIVIS LABORATORIES ₹167,091.0 Cr -2.1% -2.8% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,555.0 Cr -0.9% -0.6% 12.2% Stock Analytics
CIPLA ₹120,919.0 Cr -1% -1.2% 3.6% Stock Analytics
DR REDDYS LABORATORIES ₹106,165.0 Cr -0.1% 2.3% 2.6% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-2.7%

-11.2%

-34.8%

SENSEX

0.2%

-0.5%

4%


You may also like the below Video Courses